PCN27 COMPARATIVE BUDGET IMPACT OF FORMULARY INCLUSION OF ZOLEDRONIC ACID AND DENOSUMAB FOR PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES
May 1, 2011, 00:00
10.1016/j.jval.2011.02.885
https://www.valueinhealthjournal.com/article/S1098-3015(11)01024-2/fulltext
Title :
PCN27 COMPARATIVE BUDGET IMPACT OF FORMULARY INCLUSION OF ZOLEDRONIC ACID AND DENOSUMAB FOR PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01024-2&doi=10.1016/j.jval.2011.02.885
First page :
A159
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
352